Skip to main content
30°
Clear
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Emergent Biosolutions
(NY:
EBS
)
1.950
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Apr 25, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1
Open
1.950
Bid (Size)
1.950 (32)
Ask (Size)
2.000 (86)
Prev. Close
1.950
Today's Range
1.950 - 1.950
52wk Range
1.420 - 10.88
Shares Outstanding
52,200,000
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Emergent BioSolutions to Release First Quarter 2024 Financial Results & Conduct Conference Call on May 1, 2024
April 22, 2024
From
Emergent BioSolutions
Via
GlobeNewswire
Aquestive Therapeutics Strengthens Board of Directors with Experienced Biotech Executive
April 01, 2024
Appoints Abigail “Abbey” Jenkins, a veteran biotech executive with over 20 years of experience in commercial leadership, to Board of Directors
From
Aquestive Therapeutics, Inc.
Via
GlobeNewswire
Performance
YTD
-24.71%
-24.71%
1 Month
-20.08%
-20.08%
3 Month
+4.84%
+4.84%
6 Month
-9.30%
-9.30%
1 Year
-78.31%
-78.31%
More News
Read More
Emergent BioSolutions Continues to Broaden Access, Awareness and Availability of NARCAN® Nasal Spray to Help Save Lives from the Ongoing Opioid Crisis
March 28, 2024
From
Emergent BioSolutions
Via
GlobeNewswire
Emergent BioSolutions: Q4 Earnings Insights
March 06, 2024
Via
Benzinga
Emergent BioSolutions's Earnings: A Preview
March 04, 2024
Via
Benzinga
Emergent BioSolutions Receives NAI Status for Baltimore Bayview Manufacturing Facility
March 25, 2024
From
Emergent BioSolutions
Via
GlobeNewswire
Why HighPeak Energy Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
March 07, 2024
Via
Benzinga
Why Is Emergent BioSolutions (EBS) Stock Up 70% Today?
February 21, 2024
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's Pre-Market Session
March 07, 2024
Via
Benzinga
Why Rush Street Interactive Shares Are Trading Higher By Around 25%; Here Are 20 Stocks Moving Premarket
March 07, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
March 07, 2024
Via
InvestorPlace
Emergent BioSolutions (EBS) Q4 2023 Earnings Call Transcript
March 06, 2024
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
EBS Stock Earnings: Emergent BioSolutions Misses EPS, Misses Revenue for Q4 2023
March 06, 2024
Via
InvestorPlace
Emergent BioSolutions Reports Q4 Results, Amends Credit Agreement
March 06, 2024
Via
Benzinga
Emergent BioSolutions Reports Fourth Quarter 2023 Financial Results
March 06, 2024
From
Emergent BioSolutions
Via
GlobeNewswire
Emergent BioSolutions to Release Fourth Quarter & Full Year 2023 Financial Results, and Conduct Conference Call on March 6, 2024
February 29, 2024
From
Emergent BioSolutions
Via
GlobeNewswire
Earnings Scheduled For March 6, 2024
March 06, 2024
Via
Benzinga
Earnings Scheduled For March 5, 2024
March 05, 2024
Via
Benzinga
What's Going On Emergent BioSolutions Shares Today?
February 22, 2024
Via
Benzinga
Why International Flavors & Fragrances Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
February 21, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
February 21, 2024
Via
Benzinga
Emergent BioSolutions Inc. (NYSE: EBS) is One of Wednesday Morning’s Most Active Stocks
February 21, 2024
Via
Investor Brand Network
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
February 21, 2024
Via
Benzinga
Emergent BioSolutions Appoints Industry Leader Joseph C. Papa as New President and CEO
February 21, 2024
From
Emergent BioSolutions
Via
GlobeNewswire
Contrarian Calls: 7 Analyst ‘Sell’ Ratings That Should Be ‘Buys’
January 31, 2024
Via
InvestorPlace
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.